Screener
Altimmune ALT Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Altimmune’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326190-26-000040
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accrued professional services | $1,009 | $923 |
| Accrued payroll and employee benefits | 2,636 | 4,676 |
| Accrued research and development | 5,570 | 6,110 |
| Lease obligation, current portion | 265 | 256 |
| Accrued interest and other | 313 | 315 |
| Total accrued expenses and other current liabilities | $9,793 | $12,280 |
Item 1. Financial Statements
FAQ
- What is Altimmune's operating lease liabilities (current)?
- Altimmune (ALT) reported operating lease liabilities (current) of $265K in Q1 2026.
- How has Altimmune's operating lease liabilities (current) changed year-over-year?
- Altimmune's operating lease liabilities (current) increased by 8.2% year-over-year, from $245K to $265K.
- What is the long-term trend for Altimmune's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Altimmune's operating lease liabilities (current) has grown at a -6.4% compound annual growth rate (CAGR), from $356.72K to $256K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Altimmune's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude